Stenotrophomonas Maltophilia in Blood Stream Infections – An Overview



Abstract Views
233

Downloads
295

Citations

Share

##plugins.themes.bootstrap3.article.sidebar##

Submitted May 14, 2023
Published Aug 31, 2023
10.24018/ejmed.2023.5.4.1801

Abstract viewed = 233 times

Table of Contents

##plugins.themes.bootstrap3.article.main##

Stenotrophomonas maltophilia (S. maltophilia) is an emerging, multidrug resistant, pathogenic non-fermenting gram-negative bacillus in both immunocompromised and immunocompetent individuals. As this organism is ubiquitous in nature, it is reported to cause hospital acquired as well as community acquired infections. It has been linked to a wide range of diseases, such as pneumonia, blood stream infections, urinary tract infections, skin and soft tissue infections, meningitis, bone and joint infections and eye infections. The significance of S. maltophilia is well documented because of its distinct antibiotic susceptibility pattern from other Non Fermenting Gram Negative Bacilli (NFGNB). As no single medication is sufficiently effective against all NFGNBs, which in turn delays the start of suitable empirical treatment and raises morbidity and mortality, accurate identification, especially of S. maltophilia is crucial. Though various rapid identification methods are available, matrix-assisted laser desorption ionization-time of fight mass spectrometry (MALDI-TOF MS), enables more accurate identification of these troublesome pathogens resulting in the initiation of appropriate treatment without delay. Reports on MALDI-TOF analysis of S. maltophilia is lacking from our country.

Keywords: Blood stream infection topical drug delivery

Downloads

Download data is not yet available.

References

  1. Joanna S Brooke. Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen. Clin Microbiol Rev. 2012;25(1): 2–41.[PubMed PMID: 22232370].
    DOI  |   Google Scholar
  2. Chang YT, Lin CY, Lu PL, Lai CC, Chen TC, Chen CY, et al. Stenotrophomonas maltophilia bloodstream infection: Comparison between community onset and hospital acquired infections. J Microbiol Immunol Infect. 2014;47:28 35. [PubMed PMID: 23040236].
    DOI  |   Google Scholar
  3. Sanchez MB, Hernández A, Martínez JL. Stenotrophomonas maltophilia drug resistance. Future Microbiol. 2009;4(6):655–660. [PubMed PMID: 19659422].
    DOI  |   Google Scholar
  4. Winn W Jr, Allen S, Janda W, Koneman E, Procop G, Schreckenberger P, et al., editors. In: Koneman's Color Atlas and textbook of Diagnostic Microbiology. USA: Lippincott Williams and Wilkins Company; Nonfermenting Gram negative bacilli. 2006;6;305-391.
     Google Scholar
  5. Gales AC, Jones RN, Forward KR, Linares J, Sader HS, Verhoef J. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: Geographic patterns, Epidemiological features, and trends in the SENTRY antimicrobial surveillance program (1997-1999) Clin Infect Dis. 2001;32:104–113. [PubMed PMID: 11320451].
    DOI  |   Google Scholar
  6. Rubin SJ, Granato PA, Wasilauskas BL. Glucose nonfermenting Gram negative bacteria. In: Lennette EH, Balows A, Hausler WJ Jr, Shadomy HJ, editors. Manual of Clinical Microbiology.1985;4:330–349.
     Google Scholar
  7. Looney WJ, Narita M, Muhlemann K. Stenotrophomonas maltophilia: An emerging opportunist human pathogen. Lancet Infect Dis. 2009;9(5):312 323. [PubMed PMID: 19393961].
    DOI  |   Google Scholar
  8. Yashodhara P, Shyamala S. Identifcation and Characterization of Non Fermenters From Clinical Specimens. Indian J Med Microbiol. 1997;15:195-7.
     Google Scholar
  9. Hugh R, Leifson E. A description of the type strain of Pseudomonas maltophilia. Int Bull Bacteriol Nomencl Taxon. 1963;13(3):133 138. [Google Scholar].
    DOI  |   Google Scholar
  10. Palleroni NJ, Bradbury JF. Stenotrophomonas, a new bacterial genus for Xanthomonas maltophilia (Hugh 1980) Swings et al. 1983. Int J Syst Bacteriol. 1993;43(3):606 609. [PubMed PMID: 8347518].
    DOI  |   Google Scholar
  11. Lipuma JJ, Bart JC, Sharon JP, Peter Vandamme AR. Burkholderia, Stenotrophomonas, Ralstonia, Cupriavidus, Pandoraea, Brevundimonas, Comamonas, Delftia and Acidovorax. Manual of Clinical Microbiology. 11th ed. Ch. 43. 2015;791 812. [Google Scholar].
    DOI  |   Google Scholar
  12. Coenye T, Vanlaere E, Falsen E, Vandamme P. Stenotrophomonas africana Drancourt et al. 1997 is a later synonym of Stenotrophomonas maltophilia (Hugh 1981) Palleroni and Bradbury 1993. Int J Syst Evol Microbiol. 2004;54:1235 1237. [PubMed PMID: 15280297].
    DOI  |   Google Scholar
  13. Fujita J, Yamadori I, Xu G, Hojo S, Negayama K, Miyawaki H, Yamaji Y, Takahara J. Clinical features of Stenotrophomonas maltophilia pneumonia in immunocompromised patients. Respir. Med. 1996;90(1):35–38. [PubMed PMID: 8857324].
    DOI  |   Google Scholar
  14. Lai C-H, Chi C-Y, Chen H-P, Chen T-L, Lei CJ, Fung C-P, et al. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect. 2004;37(6):350-358. [PubMed PMID: 15599467].
     Google Scholar
  15. Vartivarian SE, Papadakis KA, Anaissie EJ. Stenotrophomonas (Xanthomonas) maltophilia urinary tract infection. A disease that is usually severe and complicated. Arch Intern Med.1996;156(4):433-435. [PubMed PMID: 8607729].
    DOI  |   Google Scholar
  16. Bin Abdulhak AA, Zimmerman V, Al Beirouti BT, Baddour LM, Tleyjeh IM. Stenotrophomonas maltophilia infectious of intact skin: a systematic review of the literature. Diagn Microbiol Infect Dis. 2009;63:330-333. [PubMed PMID: 19070451].
    DOI  |   Google Scholar
  17. Rojas P, Garcia E, Calderón GM, Ferreira F, Rosso M. Successful treatment of Stenotrophomonas maltophilia meningitis in a preterm baby boy: a case report. J Med Case Rep. 2009;3:7389. [PubMed PMID: 19830198].
    DOI  |   Google Scholar
  18. Landrum ML, Conger NG, Forgione MA. Trimethoprim-sulfamethoxazole in the treatment of Stenotrophomonas maltophilia osteomyelitis. Clin Infect Dis 2005;40(10):1551-1552. [PubMed PMID: 15844086].
    DOI  |   Google Scholar
  19. Lin HC, Ma DH, Chen YF, Yeh LK, Hsiao CH. Late-onset intrascleral dissemination of Stenotrophomonas maltophilia scleritis after pterygium excision. Cornea. 2011;30(6):712-715. [PubMed PMID: 21173698].
    DOI  |   Google Scholar
  20. Wang W-S, Liu C-P, Lee C-M, Huang F-Y. Stenotrophomonas maltophilia bacteremia in adults: four years’ experience in a medical center in northern Taiwan. J Microbiol Immunol Infect. 2004;37(6):359-365. [PubMed PMID: 15599468].
     Google Scholar
  21. Jack DS, Patricia Brown. Sepsis, severe sepsis, and septic shock. Mandell, Douglas and Bennett’s Principle and Practice of Infectious Diseases. Volume 1, G.John EB, Rapheal Dolin,Martin JB,9th Eds., 2019;990-1008, Elsevier.[Google Scholar].
     Google Scholar
  22. Calza L, Manfredi R, Chiodo F. Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study. Infection. 2003;31(3):155–161. [PubMed PMID: 12789473].
    DOI  |   Google Scholar
  23. Metan G, Hayran M, Hascelik G, Uzun O. Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital. Scand J Infect Dis. 2006;38(6-7):527–531. [PubMed PMID: 16798705].
    DOI  |   Google Scholar
  24. Garcia Paez JI, Costa SF. Risk factors associated with mortality of infections caused by Stenotrophomonas maltophilia: a systematic review. J Hosp Infect. 2008;70(2):101–108. [PubMed PMID: 18621440].
    DOI  |   Google Scholar
  25. De Oliveira GD, Monique DA, Monica Rosales, Ana CGSA, Norma Alcantara, Marina BM, et al. Fimbriae and adherence of Stenotrophomonas maltophilia to epithelial cells and to abiotic surfaces. Cell Microbiol. 2003;5:625–636. [PubMed PMID: 12925132].
    DOI  |   Google Scholar
  26. De Oliveira GD, Monique DA, Monica Rosales, Ana CGSA, Marina BM, Jorge AG. Characterization of flagella produced by clinical strains of Stenotrophomonas maltophilia. Emerg Infect Dis. 2002;8(9): 918-923. [PubMed PMID: 12194767].
    DOI  |   Google Scholar
  27. Furuhata K, Ishizaki N, Kawakami Y, Fukuyama M. Bacterial contamination of stock solutions in storage cases for contact lens, and the disinfectant-resistance of isolates. Biocontrol Sci. 2010;15(3):81–85. [PubMed PMID: 20938091].
    DOI  |   Google Scholar
  28. Pompilio Arianna, Valentina Crocetta, Pamela Confalone, Mauro Nicoletti, Andrea Petrucca, Simone Guarnieri, et al. Adhesion to and biofilm formation on IB3-1 bronchial cells by Stenotrophomonas maltophilia isolates from cystic fibrosis patients. BMC Microbiol. 2010;10:102. http://www.biomedcentral.com/1471-2180/10/102.
    DOI  |   Google Scholar
  29. Liaw S-J, Lee Y-L, Hsueh P-R. Multidrug resistance in clinical isolates of Stenotrophomonas maltophilia: roles of integrons, efflux pumps, phosphoglucomutase (SpgM), and melanin and biofilm formation. Int J Antimicrob Agents. 2010;35(2):126–130. [PubMed PMID: 19926255].
    DOI  |   Google Scholar
  30. Potera C. Forging a link between biofilms and disease. Science. 1999;283:1837–1838. [PubMed PMID: 10206887].
    DOI  |   Google Scholar
  31. Lipika Singhal, Parvinder Kaur, Vikas Gautam. Stenotrophomonas maltophilia: From Trivial to Grievous. Indian J of Med Microbiol. 2017;35(4):469-479. [PubMed PMID: 29405136].
    DOI  |   Google Scholar
  32. Figueiredo PMS, Furumura MT, Santos AM, Sousa ACT, Kota DJ, Levy CE, et al. Cytotoxic activity of clinical Stenotrophomonas maltophilia. Lett Appl Microbiol. 2006;43(4):443–449. [PubMed PMID: 16965377].
    DOI  |   Google Scholar
  33. De Abreu VL, de Andrade ME, Puchelle E, Plotkowski MC. Stenotrophomonas maltophilia interaction with human epithelial respiratory cells in vitro. Microbiol Immunol. 2001;45(8):563–569. [Google Scholar].
    DOI  |   Google Scholar
  34. Andrew EC, Erin JK, Amit A, Donna MW. Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry: a fundamental shift in the routine practice of clinical microbiology. Clin. Microbiol. Reviews. 2013;25(3):547-603. [PubMed PMID: 23824373].
    DOI  |   Google Scholar
  35. Vasileuskaya Schulz Z, Kaiser S, Maier T, Kostrzewa M, Jonas D. Delineation of Stenotrophomonas spp. By multi locus sequence analysis and MALDI TOF mass spectrometry. Syst Appl Microbiol 2011;34(1):35 39. [PubMed PMID: 21247714].
    DOI  |   Google Scholar
  36. Gautam V, Sharma M, Singhal L, Kumar S, Kaur P, Tiwari R, et al. MALDI TOF mass spectrometry: An emerging tool for unequivocal identification of non fermenting gram negative bacilli. Indian J Med Res. 2017;145(5):665 672. [PubMed PMID: 28948958].
     Google Scholar
  37. Wang W-S, Liu C-P, Lee C-M, Huang F-Y. Stenotrophomonas maltophilia bacteremia in adults: four years’ experience in a medical center in northern Taiwan. J Microbiol Immunol Infect. 2004;37(6):359-365. [PubMed PMID: 15599468].
     Google Scholar
  38. Senol E, DesJardin J, Stark PC, Barefoot L, Snydman DR. Attributable mortality of Stenotrophomonas maltophilia bacteremia. Clin Infect Dis. 2002;34(12):1653 1656. [PubMed PMID: 12032905].
    DOI  |   Google Scholar
  39. Aisenberg G, Rolston KV, Dickey BF, Kontoyiannis DP, Raad II, Safdar A, et al. Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997 2004. Eur J Clin Microbiol Infect Dis. 2007;26:13 20. [PubMed PMID: 17200840].
    DOI  |   Google Scholar
  40. Yibing Chen, Jijiang Suo, Mingmei Du, Liangan Chen, Yunxi Liu, Leili Wang, et al. Clinical Features, Outcomes, and Risk Factors of Bloodstream Infections due to Stenotrophomonas maltophilia in a Tertiary-Care Hospital of China: A Retrospective Analysis. BioMed Research International. 2019:4931501. [PubMed PMID: 31886220].
    DOI  |   Google Scholar
  41. Emerson J, McNamara S, Buccat AM, Worrell K, Burns JL. Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008. Pediatr Pulmonol. 2010;45(4):363 370. [PubMed PMID: 20232473].
    DOI  |   Google Scholar
  42. Jones RN. Microbial etiologies of hospital acquired bacterial pneumonia and ventilator associated bacterial pneumonia. Clin Infect Dis. 2010;51(1): 81 87. [PubMed PMID: 20597676]
    DOI  |   Google Scholar
  43. Gautam V, Singhal L, Ray P. Burkholderia cepacia complex: Beyond Pseudomonas and acinetobacter. Indian J Med Microbiol 2011; 29(1): 4-12. [PubMed PMID: 21304187].
    DOI  |   Google Scholar
  44. Nonika Rajkumari1, Purva Mathur, Amit KG, Kumkum Sharma, Mahesh CM. Epidemiology and outcomes of Stenotrophomonas maltophilia and Burkholderia cepacia infections among trauma patients of India: a five year experience. Journal of Infection Prevention. 2015;16(3):103-110. [PubMed PMID: 28989412].
    DOI  |   Google Scholar
  45. Das T, Deshmukh HS, Mathai A, Reddy AK. Stenotrophomonas maltophilia endogenous endophthalmitis: Clinical presentation, sensitivity spectrum and management. J Med Microbiol. 2009;58:837 838. [PubMed PMID: 19429764].
    DOI  |   Google Scholar
  46. Thomas J, Prabhu VN, Varaprasad IR, Agrawal S, Narsimulu G. Stenotrophomonas maltophilia: A very rare cause of tropical pyomyositis. Int J Rheum Dis 2010;13(1):89 90. [PubMed PMID: 20374391].
    DOI  |   Google Scholar
  47. Viswanathan R, Singh AK, Ghosh C, Basu S. Stenotrophomonas maltophilia causing early onset neonatal sepsis. Indian Pediatr 2011;48(5):397 399. [PubMed PMID: 21654005].
     Google Scholar
  48. Mahendradas P, Avadhani K, Anandula V, Shetty R. Unilateral conjunctival ulcer due to Stenotrophomonas maltophilia infection. Indian J Ophthalmol. 2012;60(2):134 136. [PubMed PMID: 22446910].
    DOI  |   Google Scholar
  49. Nag F, De A, Banerjee K, Chatterjee G. Non healing leg ulcer infected with Stenotrophomonas maltophilia: First reported case from India. Int Wound J. 2013;10(3):356 358. [PubMed PMID: 22289105].
    DOI  |   Google Scholar
  50. Sood S, Vaid VK, Bhartiya H. Meningitis due to Stenotrophomonas maltophilia after a neurosurgical procedure. J Clin Diagn Res. 2013;7(8):1696 1697. [PubMed PMID: 24086879].
    DOI  |   Google Scholar
  51. Malini A, Deepa E, Gokul B, Prasad S. Nonfermenting gram negative bacilli infections in a tertiary care hospital in Kolar, Karnataka. J Lab Physicians. 2009;1(2):62 66. [PubMed PMID: 21938252].
    DOI  |   Google Scholar
  52. Gautam V, Kumar S, Kaur P, Deepak T, Singhal L, Tewari R, et al. Antimicrobial susceptibility pattern of Burkholderia cepacia complex & Stenotrophomonas maltophilia from North India: Trend over a decade (2007 2016). Indian J Med Res. 2020;152(6):656-661. [PubMed PMID: 34145106].
    DOI  |   Google Scholar